Novel antibiotic BTZ-043 can also target TB bacteria hiding in dead lung tissue

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment of TB usually requires several months of antibiotic therapy, but the rise of drug-resistant forms of TB has led to an urgent need for new drugs.